A Strategy to Reduce Stunting of Growth in Early Infancy: a Global Network Study

减少婴儿早期生长迟缓的策略:全球网络研究

基本信息

  • 批准号:
    8658452
  • 负责人:
  • 金额:
    $ 55.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-03 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Democratic Republic of Congo (DRC) is among the poorest nations in the world with correspondingly poor health outcomes. Innovative research is urgently needed to discover evidence-based interventions to improve health outcomes in low income countries. The health care environment and outcomes in the DRC are emblematic of problems encountered in many low income countries making the DRC an ideal environment in which to develop and test strategies for improving the health of women and children in these countries. The University of North Carolina at Chapel Hill (UNC) and the Kinshasa School of Public Health (KSPH) in the DRC have had a longstanding partnership whose overall goal has been to expand scientific knowledge relevant to improving health outcomes. The Partnership, led by Dr. Antoinette Tshefu (KSPH), and Drs. Carl Bose and Frieda Behets (UNC), has been highly productive in a wide range of hospital and community-based research studies, and has the expertise and resources to address research questions in a variety of areas of maternal and child health. Therefore, the UNC-KSPH Partnership is an ideal candidate to resume membership in the GN. A recent research interest of the Partnership has been early childhood malnutrition, which often begins during the first six months of life. The consequences of malnutrition at this vulnerable age include stunting of linear growth, impaired neurodevelopment and a number of long term health problems. A possible cause of stunting prior to 6 months of age is environmental enteropathy secondary to intestinal parasitic infection. As a member of the GN, we propose a multi-national study of a strategy to reduce stunting in early infancy that includes the identification and treatment of intestinal parasites. In this study, we will use the ati-parasitic drug, mebendazole. Because there is little knowledge about the pharmacokinetics (PK) and safety of this drug (or any other anti-parasitic drugs) in infants, we will also perform PK and safety studies of the treatment. Public Health Relevance: In developing countries, a major health problem is malnutrition; the most obvious manifestation in children is stunting of growth. Stunting often begins in early infancy and may be caused by environmental enteropathy. We propose a multi-national study of a strategy to reduce stunting in infancy that includes the early identification and treatment of intestinal parasites, a common cause of environmental enteropathy.
描述(申请人提供):刚果民主共和国(DRC)是世界上最贫穷的国家之一,健康状况也相应较差。迫切需要进行创新研究,以发现循证干预措施,改善低收入国家的健康状况。刚果民主共和国的卫生保健环境和成果是许多低收入国家遇到的问题的象征,使刚果民主共和国成为制定和测试改善这些国家妇女和儿童健康战略的理想环境。位于查佩尔山的北卡罗来纳州大学和刚果民主共和国的金沙萨公共卫生学院建立了长期的伙伴关系,其总体目标是扩大与改善健康结果有关的科学知识。该伙伴关系由Antoinette Tshefu博士(KSPH)和Carl Bose博士和Frieda Behets博士(KSPH)领导,在广泛的医院和社区研究中富有成效,并拥有解决孕产妇和儿童健康各个领域研究问题的专业知识和资源。因此,UNC-KSPH伙伴关系是恢复在全球网络成员资格的理想候选者。该伙伴关系最近的一个研究兴趣是幼儿营养不良问题,这种问题往往在生命的头六个月开始。在这个脆弱年龄营养不良的后果包括线性生长发育迟缓、神经发育受损和一些长期健康问题。6个月之前发育迟缓的一个可能原因是继发于肠道寄生虫感染的环境性肠病。作为GN的一员,我们建议开展一项多国研究,研究减少婴儿早期发育迟缓的策略,包括识别和治疗肠道寄生虫。在这项研究中,我们将使用抗寄生虫药甲苯咪唑。由于对该药物(或任何其他抗寄生虫药物)在婴儿中的药代动力学(PK)和安全性知之甚少,我们还将进行PK和 治疗的安全性研究。 公共卫生相关性:在发展中国家,一个主要的健康问题是营养不良;在儿童中最明显的表现是发育迟缓。发育迟缓通常始于婴儿早期,可能是由环境性肠病引起的。我们提出了一项多国研究的战略,以减少婴儿期发育迟缓,其中包括早期识别和治疗肠道寄生虫,环境性肠病的常见原因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CARL BOSE其他文献

CARL BOSE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CARL BOSE', 18)}}的其他基金

A Strategy to Reduce Stunting of Growth in Early Infancy: a Global Network Study
减少婴儿早期生长迟缓的策略:全球网络研究
  • 批准号:
    8518797
  • 财政年份:
    2013
  • 资助金额:
    $ 55.49万
  • 项目类别:
The University of North Carolina-Kinshasa School of Public Health Research Partnership in the Democratic Republic of Congo; a Model for Improving Women'sand Children's Health Through Research
北卡罗来纳大学金沙萨分校公共卫生研究伙伴关系刚果民主共和国;
  • 批准号:
    9754216
  • 财政年份:
    2013
  • 资助金额:
    $ 55.49万
  • 项目类别:
A Strategy to Reduce Stunting of Growth in Early Infancy: a Global Network Study
减少婴儿早期生长迟缓的策略:全球网络研究
  • 批准号:
    9269596
  • 财政年份:
    2013
  • 资助金额:
    $ 55.49万
  • 项目类别:
The University of North Carolina-Kinshasa School of Public Health Research Partnership in the Democratic Republic of Congo; a Model for Improving Women'sand Children's Health Through Research
北卡罗来纳大学金沙萨分校公共卫生研究伙伴关系刚果民主共和国;
  • 批准号:
    9605614
  • 财政年份:
    2013
  • 资助金额:
    $ 55.49万
  • 项目类别:
Safe Pregnancy by Infectious Disease Control in Kinshasa
金沙萨通过传染病控制实现安全怀孕
  • 批准号:
    7689556
  • 财政年份:
    2003
  • 资助金额:
    $ 55.49万
  • 项目类别:
Safe Pregnancy by Infectious Disease Control in Kinshasa
金沙萨通过传染病控制实现安全怀孕
  • 批准号:
    7080451
  • 财政年份:
    2003
  • 资助金额:
    $ 55.49万
  • 项目类别:
Safe Pregnancy by Infectious Disease Control in Kinshasa
金沙萨通过传染病控制实现安全怀孕
  • 批准号:
    7275983
  • 财政年份:
    2003
  • 资助金额:
    $ 55.49万
  • 项目类别:
Safe Pregnancy by Infectious Disease Control in Kinshasa
金沙萨通过传染病控制实现安全怀孕
  • 批准号:
    6895871
  • 财政年份:
    2003
  • 资助金额:
    $ 55.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了